资产负债表（Pacific Biosciences of California Inc）
| 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | |||||||
| 现金及现金等价物(元) | 385,648,000.00 | 209,287,000.00 | 353,834,000.00 | 325,089,000.00 | 304,433,000.00 | 310,445,000.00 | 428,574,000.00 |
| 受限制存款及现金流动(元) | 300,000.00 | 300,000.00 | 300,000.00 | 300,000.00 | 300,000.00 | 300,000.00 | 500,000.00 |
| 应收账款及票据(元) | 30,486,000.00 | 24,034,000.00 | 29,589,000.00 | 18,786,000.00 | 22,756,000.00 | 27,058,000.00 | 27,852,000.00 |
| 预付款项及其他应收款流动(元) | 15,466,000.00 | 13,748,000.00 | 14,375,000.00 | 10,289,000.00 | 13,005,000.00 | 7,657,000.00 | 8,436,000.00 |
| 存货(元) | 68,256,000.00 | 67,608,000.00 | 61,955,000.00 | 50,381,000.00 | 43,495,000.00 | 36,121,000.00 | 29,625,000.00 |
| 短期投资(元) | 382,141,000.00 | 620,575,000.00 | 521,058,000.00 | 447,229,000.00 | 529,907,000.00 | 588,706,000.00 | 534,201,000.00 |
| 流动资产合计(元) | 882,297,000.00 | 935,552,000.00 | 981,111,000.00 | 852,074,000.00 | 913,896,000.00 | 970,287,000.00 | 1,029,188,000.00 |
| 非流动资产： | |||||||
| 物业、厂房及设备(元) | 40,340,000.00 | 40,317,000.00 | 40,833,000.00 | 41,580,000.00 | 39,154,000.00 | 37,957,000.00 | 35,510,000.00 |
| 受限制存款及现金非流动(元) | 2,422,000.00 | 2,422,000.00 | 2,922,000.00 | 2,922,000.00 | 2,922,000.00 | 2,922,000.00 | 4,982,000.00 |
| 无形资产(元) | 461,838,000.00 | 409,779,000.00 | 410,011,000.00 | 410,245,000.00 | 410,294,000.00 | 410,523,000.00 | 410,751,000.00 |
| 商誉(元) | 463,843,000.00 | 409,974,000.00 | 409,974,000.00 | 409,974,000.00 | 409,974,000.00 | 409,974,000.00 | 409,974,000.00 |
| 非流动资产其他项目(元) | 47,614,000.00 | 49,587,000.00 | 51,566,000.00 | 50,291,000.00 | 42,709,000.00 | 44,479,000.00 | 46,261,000.00 |
| 非流动资产合计(元) | 1,016,057,000.00 | 912,079,000.00 | 915,306,000.00 | 915,012,000.00 | 905,053,000.00 | 905,855,000.00 | 907,478,000.00 |
| 总资产(元) | 1,898,354,000.00 | 1,847,631,000.00 | 1,896,417,000.00 | 1,767,086,000.00 | 1,818,949,000.00 | 1,876,142,000.00 | 1,936,666,000.00 |
| 流动负债： | |||||||
| 融资租赁负债流动(元) | 9,460,000.00 | 9,243,000.00 | 9,018,000.00 | 8,886,000.00 | 8,612,000.00 | - | - |
| 应付账款及票据(元) | 16,106,000.00 | 16,512,000.00 | 17,390,000.00 | 12,028,000.00 | 12,853,000.00 | 12,883,000.00 | 17,607,000.00 |
| 其他应付款及应计费用(元) | 34,660,000.00 | 27,010,000.00 | 19,380,000.00 | 32,596,000.00 | 24,886,000.00 | 25,174,000.00 | 19,489,000.00 |
| 递延收入流动(元) | 22,372,000.00 | 24,983,000.00 | 30,866,000.00 | 30,498,000.00 | 30,689,000.00 | 32,084,000.00 | 12,729,000.00 |
| 流动负债其他项目(元) | 101,363,000.00 | 193,661,000.00 | 189,020,000.00 | 179,327,000.00 | 4,609,000.00 | 14,255,000.00 | 11,185,000.00 |
| 流动负债合计(元) | 183,961,000.00 | 271,409,000.00 | 265,674,000.00 | 263,335,000.00 | 81,649,000.00 | 84,396,000.00 | 61,010,000.00 |
| 非流动负债： | |||||||
| 融资租赁负债非流动(元) | 34,100,000.00 | 36,599,000.00 | 38,969,000.00 | 41,070,000.00 | 43,163,000.00 | - | - |
| 衍生工具负债非流动(元) | 891,996,000.00 | 891,795,000.00 | 896,839,000.00 | 896,683,000.00 | 896,529,000.00 | 896,374,000.00 | 896,220,000.00 |
| 递延收入非流动(元) | 5,053,000.00 | 4,992,000.00 | 1,849,000.00 | 1,794,000.00 | 1,762,000.00 | 1,827,000.00 | 25,246,000.00 |
| 非流动负债其他项目(元) | 19,501,000.00 | 837,000.00 | 969,000.00 | 1,300,000.00 | 169,255,000.00 | 211,659,000.00 | 219,612,000.00 |
| 非流动负债合计(元) | 950,650,000.00 | 934,223,000.00 | 938,626,000.00 | 940,847,000.00 | 1,110,709,000.00 | 1,109,860,000.00 | 1,141,078,000.00 |
| 总负债(元) | 1,134,611,000.00 | 1,205,632,000.00 | 1,204,300,000.00 | 1,204,182,000.00 | 1,192,358,000.00 | 1,194,256,000.00 | 1,202,088,000.00 |
| 股东权益： | |||||||
| 普通股(元) | 258,000.00 | 250,000.00 | 250,000.00 | 227,000.00 | 226,000.00 | 225,000.00 | 224,000.00 |
| 股本溢价(元) | 2,522,382,000.00 | 2,334,623,000.00 | 2,314,146,000.00 | 2,099,782,000.00 | 2,080,581,000.00 | 2,058,103,000.00 | 2,038,030,000.00 |
| 留存收益(元) | -1,757,057,000.00 | -1,690,188,000.00 | -1,620,355,000.00 | -1,532,340,000.00 | -1,447,956,000.00 | -1,370,985,000.00 | -1,299,591,000.00 |
| 累计其他全面收益(元) | -1,840,000.00 | -2,686,000.00 | -1,924,000.00 | -4,765,000.00 | -6,260,000.00 | -5,457,000.00 | -4,085,000.00 |
| 归属于母公司股东权益(元) | 763,743,000.00 | 641,999,000.00 | 692,117,000.00 | 562,904,000.00 | 626,591,000.00 | 681,886,000.00 | 734,578,000.00 |
| 股东权益合计(元) | 763,743,000.00 | 641,999,000.00 | 692,117,000.00 | 562,904,000.00 | 626,591,000.00 | 681,886,000.00 | 734,578,000.00 |
| 负债及股东权益合计(元) | 1,898,354,000.00 | 1,847,631,000.00 | 1,896,417,000.00 | 1,767,086,000.00 | 1,818,949,000.00 | 1,876,142,000.00 | 1,936,666,000.00 |
| 公告日期 | 2023-11-03 | 2023-08-04 | 2023-05-04 | 2023-02-28 | 2022-11-08 | 2022-08-08 | 2022-05-06 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | |||||||
| 核数师 |